Dong Hui Yang
Oprichter bij Hangzhou Adlai Nortye Biopharma Co. Ltd.
Actieve functies van Dong Hui Yang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Directeur/Bestuurslid | - | - |
| Oprichter | 01-01-2004 | - | |
| Corporate Officer/Principal | - | - |
Loopbaan van Dong Hui Yang
Eerdere bekende functies van Dong Hui Yang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ADLAI NORTYE LTD. | Directeur/Bestuurslid | 01-06-2018 | - |
| Corporate Officer/Principal | - | - |
Opleiding van Dong Hui Yang
| Jiangxi Normal University | Undergraduate Degree |
| South China Normal University | Graduate Degree |
Statistieken
Internationaal
| China | 5 |
Operationeel
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectoraal
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
- Beurs
- Insiders
- Dong Hui Yang
- Ervaring
